Vaccine-Based Immunotherapy Regimen For NSCLC and TNBC
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Non-Small Cell Lung Cancer|Triple-negative Breast Cancer
Interventions: BIOLOGICAL: PF-06936308
Sponsor: Pfizer